Loading clinical trials...
Loading clinical trials...
Hypoxia is a known factor for resistance to radiotherapy in tumors. Response to transarterial radioembolization is known to be variable between different patients even if the same dose of radiation wa...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ankara University
NCT05468034 · Breast Cancer, Indolent Metastatic Breast Cancer
NCT04541381 · Gastrointestinal Cancer, Head and Neck Cancer, and more
NCT06926283 · Prostate Cancer, Other Solid Tumors, and more
NCT05671510 · Non Small Cell Lung Cancer
NCT07446322 · Ras-mutated Metastatic Colorectal Cancer, mCRC, and more
Ankara University
Ankara
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions